Stathmin is a major cytosolic phosphoprotein that is highly expressed in le
ukemic cells and many other malignant cell types. The high level of stathmi
n expression in a wide variety of cancer cells suggested that this phosphop
rotein may play a role in the process of malignant tr transformation. We co
mpared the levels of stathmin expression in low passage primary embryonic f
ibroblasts and in their immortalized counterparts. The immortalized cells h
ad a markedly higher rate of proliferation that was associated with a four
fold increase in the level of stathmin expression. In contrast, transformat
ion of the immortalized fibroblasts with seven different activated oncogene
s did not result in significant changes in the level of stathmin expression
nor in a consistent increase in their rate of proliferation. These observa
tions do not support a direct role for the activation of stathmin gene expr
ession in the transformed phenotype. We suggest that the increased levels o
f stathmin in transformed cells compared to non-transformed cells may be a
reflection of differences in their rate of proliferation and state of diffe
rentiation.